Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 154
Genomics 73
Biopharmaceuticals 73
Immune Disorders Drugs 71
Biotechnology 50
Pharmaceuticals 42
Oncology Drugs 41
Musculoskeletal Disorders Drugs 41
Drug Discovery 37
Hematological Drugs 36
Biosimilars and Biosuperiors 31
Alzheimer's Disease Drugs 26
Infusions and Injectables 25
Cardiovascular Drugs 24
Allergy and Immunology 22
Clinical Trials 22
Optical Disorders Drugs 21
Mental Disorders Drugs 19
Neurology 17
Needles and Syringes 17
E-Healthcare 14
Respiratory Drugs 14
Psoriasis Drugs 14
Infectious Diseases Drugs 12
Optical 12
Immunosuppressive Drugs 12
Healthcare Services 11
Hematology 11
Gastrointestinal Drugs 11
Pharmaceutical Manufacturing 11
Drug Delivery 10
Drugs by Therapeutic Area 9
Lymphoma Drugs 9
Analgesics 9
Diagnostics 9
Endocrine and Metabolic Disorders Drugs 9
Therapeutic Area 8
Leukemia Drugs 8
Pulmonary Medicine 7
Liver and Kidney Disorders Drugs 7
Enzymes 5
Medical Devices 5
Oncology 5
Schizophrenia Drugs 5
Company Reports 4
Proteomics 4
Mental Health 4
Neurology Devices 4
Cardiology 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Stem Cells 3
Hospital Management 3
Dermatology 3
Vitamins and Dietary Supplements 3
Gastroenterology 3
Dermatological Drugs 3
Urology and Nephrology 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
In Vitro Diagnostics 2
Managed Care 2
Diabetes Devices 2
Biomaterials 2
Biomarkers 2
Vaccines 2
Skin Cancer Drugs 2
Laboratory Equipment 2
Pediatrics 2
Anxiety Drugs 2
Addiction Disorders Drugs 1
Diabetes Drugs 1
Women's Health 1
Fertility Services 1
Lung Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Brain Cancer Drugs 1
Medical Imaging 1
Infectious Disease Testing 1
Transdermal and Transmucosal Drug Delivery 1
Contrast Media 1
Kidney Cancer Drugs 1
Nanomedicine 1
Antibiotics 1
Clinical Skills 1
Anatomy 1
Endocrinology 1
Allergy Drugs 1
Asthma Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

855 Results (Page 18 of 43)
- Relevance
  Sort by

Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

 Report
October 2021
288 Pages
Global

From

€3181EUR$3,600USD£2,785GBP

Trigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

 Report
October 2023
105 Pages
Global

From

€2209EUR$2,500USD£1,934GBP

Immunomodulators Market Report by Product (Immunosuppressants, Immunostimulants), Application (Oncology, Respiratory, HIV, and Others), and Region 2025-2033

 Report
September 2025
150 Pages
Global

From

€2253EUR$2,549USD£1,972GBP

€2650EUR$2,999USD£2,320GBP

Rare Diseases Treatment Market - Global Forecast 2025-2032

 Report
November 2025
196 Pages
Global

From

€3133EUR$3,545USD£2,743GBP

€3481EUR$3,939USD£3,047GBP

Licensing Deals in Pharmaceuticals 2020-2025

 Report
September 2025
1000 Pages
Global

From

€4414EUR$4,995USD£3,864GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Collaboration Deals in Pharmaceuticals 2020-2025

 Report
September 2025
950 Pages
Global

From

€4414EUR$4,995USD£3,864GBP

Generic Pharmaceuticals Market Report 2025

 Report
March 2025
250 Pages
Global

From

€3968EUR$4,490USD£3,474GBP

Prostate Cancer Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3968EUR$4,490USD£3,474GBP

Anxiety Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
190 Pages
Global

From

€3977EUR$4,500USD£3,481GBP

Cognitive Disorders Treatment Market - Global Strategic Business Report

 Report
December 2025
373 Pages
Global

From

€5170EUR$5,850USD£4,526GBP

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

 Report
January 2019
230 Pages
Global

From

€3534EUR$3,999USD£3,094GBP

Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
94 Pages
Global

From

€1767EUR$2,000USD£1,547GBP

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
589 Pages
Global

From

€2209EUR$2,500USD£1,934GBP

Biosimilars Market - Global Forecast 2025-2032

 Report
November 2025
192 Pages
Global

From

€3133EUR$3,545USD£2,743GBP

€3481EUR$3,939USD£3,047GBP

Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

 Report
April 2023
397 Pages
Global

From

€2209EUR$2,500USD£1,934GBP

Digital Biomarkers Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product, Purpose of Solution, Type of Biomarker, Therapeutic Area, Business Model and Key Geographical Regions

 Report
April 2025
369 Pages
Global

From

€4241EUR$4,799USD£3,713GBP

Biosimilars Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3968EUR$4,490USD£3,474GBP

Biologic & Biosimilar RA Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3968EUR$4,490USD£3,474GBP

Biobetters Market by Drug Class, by Disease Indication, by Route of Administration, by Distribution Channel, and By Region

 Report
March 2024
200 Pages
Global

From

€3667EUR$4,150USD£3,211GBP

Multiple Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

 Report
January 2023
1452 Pages
Global

From

€4418EUR$5,000USD£3,868GBP

855 Results (Page 18 of 43)
- 1
- 16
- 17
- 18
- 19
- 20

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.